X
NGVT icon

Xponance’s Ingevity NGVT Stock Holding History

Xponance’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
3,510
+134
+4% +$9.65K ﹤0.01% 1486
2026
Q1 		$240K Buy
+3,376
New +$231K ﹤0.01% 1386
2023
Q2 		– Sell
-5,866
Closed -$420K – 1277
2023
Q1 		$420K Hold
5,866
– – 0.01% 958
2022
Q4 		$413K Sell
5,866
-141
-2% -$9.94K 0.01% 950
2022
Q3 		$364K Sell
6,007
-399
-6% -$26.8K 0.01% 946
2022
Q2 		$404K Buy
6,406
+254
+4% +$16.6K 0.01% 938
2022
Q1 		$395K Sell
6,152
-108
-2% -$7.22K 0.01% 969
2021
Q4 		$449K Sell
6,260
-74
-1% -$5.63K 0.01% 942
2021
Q3 		$452K Sell
6,334
-400
-6% -$31.5K 0.01% 931
2021
Q2 		$548K Buy
6,734
+1,854
+38% +$149K 0.01% 884
2021
Q1 		$369K Sell
4,880
-653
-12% -$47.5K 0.01% 900
2020
Q4 		$419K Buy
5,533
+24
+0.4% +$1.56K 0.01% 821
2020
Q3 		$272K Sell
5,509
-113
-2% -$6.38K 0.01% 893
2020
Q2 		$296K Buy
+5,622
New +$267K 0.01% 835

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Xponance's NGVT Position: Q2 2026 in Review

Xponance increased its Ingevity (NGVT) stake by 4% in Q2 2026, buying an estimated $9.65K and bringing the position to 3,510 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Xponance first reported a position in NGVT in Q2 2020 and has held it in 14 quarters since. The position peaked at $548K in Q2 2021. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Xponance held 3,510 shares of Ingevity worth $262K as of Q2 2026.
  • Xponance bought 134 Ingevity shares in Q2 2026, an estimated $9.65K.
  • Ingevity made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1486 holding.
  • Xponance first reported a position in Ingevity in Q2 2020 and has held it in 14 quarters since.
  • Xponance's Ingevity position peaked at $548K in Q2 2021.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.